Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases

Use of vasopeptidase inhibitors in the treatment of metabolic diseases, nephropathy and advanced glycation end-product associated diseases

US Patent 6930103 · Granted Aug 16, 2005

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Protective shroud for aircraft tail rotor2025
Soluble guanylate cyclase activators for treating portal hypertension2025
Alkoxy pyrazoles as soluble guanylate cyclase activators2023
Cyanide-free electrolyte composition and method for the deposition of silver or 2017
Cyanide-free electrolyte composition, and method for the deposition of silver or2015
Block piece for holding an optical workpiece, in particular a spectacle lens, fo2014
Cyanide free electrolyte composition for the galvanic deposition of a copper lay2014
Synthetic double-stranded oligonucleotides for specific inhibition of gene expre2014
Membrane module for immersed operation2013
Airbag device for protecting a vehicle occupant2012
Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and a2012
Membrane filter unit and method for the production of the membrane filter unit2011